title: Inducing hyperkalemia by converting enzyme inhibitors and heparin.
authors.affiliation: Service de Néphrologie, Chu Toulouse-Rangueil, France.
authors.forename: D
authors.initials: D
authors.lastname: Durand
authors.forename: J L
authors.initials: JL
authors.lastname: Ader
authors.forename: J P
authors.initials: JP
authors.lastname: Rey
authors.forename: T
authors.initials: T
authors.lastname: Tran-Van
authors.forename: J J
authors.initials: JJ
authors.lastname: Lloveras
authors.forename: P
authors.initials: P
authors.lastname: Bernadet
authors.forename: J M
authors.initials: JM
authors.lastname: Suc
mesh_terms: D000138:Acidosis / Q000150:complications; D058186:Acute Kidney Injury / Q000150:complications; D000450:Aldosterone / Q000097:blood; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005110:Extracellular Space / Q000378:metabolism; D006493:Heparin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced*; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D007676:Kidney Failure, Chronic / Q000150:complications / Q000188:drug therapy; D011188:Potassium / Q000097:blood
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000450:Aldosterone; D006493:Heparin; D011188:Potassium